Pneumoconioses (Asbestos-related disease)

Pneumoconioses (Asbestos-related disease) is a lung condition caused by breathing in tiny fibers of asbestos, a material once commonly used in construction and manufacturing. These fibers can get trapped in the lungs and cause irritation and scarring over time. The main body system affected is the respiratory system, specifically the lungs. This scarring can make it harder to breathe and reduce the lungs' ability to take in oxygen. People with this condition may develop symptoms like shortness of breath, a persistent cough, and chest tightness. Long-term exposure to asbestos can also increase the risk of serious lung diseases, including lung cancer and a rare cancer called mesothelioma. The disease often develops many years after exposure.

Pneumoconioses (Asbestos-related disease) is a chronic interstitial lung disease caused by inhalation of asbestos fibers, leading to fibrotic lung changes and impaired pulmonary function. The core pathology involves asbestos fiber deposition in the alveoli and interstitium, triggering a persistent inflammatory response and progressive pulmonary fibrosis. This condition is a subset of pneumoconioses characterized by pleural plaques, diffuse interstitial fibrosis, and increased risk of malignant mesothelioma and bronchogenic carcinoma. The disease typically manifests after a latency period of 10 to 40 years following occupational or environmental exposure. Clinically, it presents with progressive dyspnea, dry cough, and restrictive lung physiology. Radiographically, pleural thickening and interstitial fibrosis are hallmark findings. The disease is significant due to its irreversible nature and potential for severe respiratory compromise and malignancy.